Immunic, Inc. Cash and Restricted Cash
Immunic, Inc. (IMUX) had Cash and Restricted Cash of $155.10 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-11
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $155.10M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $186.63M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $15.48M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $35.13M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $155.10M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $186.63M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $15.48M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $35.13M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $55.31M 10-Q · filed 2026-08-11 |
| 2025-03-31 | $14.30M 10-Q · filed 2026-05-13 |
| 2024-12-31 | $35.67M 10-Q · filed 2026-08-11 |
| 2024-09-30 | $59.07M 10-Q · filed 2025-11-13 |
| 2024-06-30 | $79.70M 10-Q · filed 2025-08-07 |
| 2024-03-31 | $97.31M 10-Q · filed 2025-05-15 |
| 2023-12-31 | $46.67M 10-K · filed 2026-02-26 |
| 2023-09-30 | $59.69M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $77.29M 10-Q · filed 2024-08-08 |
| 2023-03-31 | $92.76M 10-Q · filed 2024-05-08 |
| 2022-12-31 | $106.75M 10-K · filed 2025-03-31 |
| 2022-09-30 | $72.77M 10-Q · filed 2023-11-14 |
| 2022-06-30 | $88.08M 10-Q · filed 2023-08-03 |
| 2022-03-31 | $95.71M 10-Q · filed 2023-05-11 |
| 2021-12-31 | $86.86M 10-K · filed 2024-02-22 |
| 2021-09-30 | $110.44M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $87.17M 10-Q · filed 2022-08-04 |
| 2021-03-31 | $114.84M 10-Q · filed 2022-05-10 |
| 2020-12-31 | $127.45M 10-K · filed 2023-02-23 |
| 2020-09-30 | $133.18M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $48.61M 10-Q · filed 2021-08-06 |
| 2020-03-31 | $18.58M 10-Q · filed 2021-05-06 |
| 2019-12-31 | $29.37M 10-K · filed 2022-02-24 |
| 2019-09-30 | $30.46M 10-Q · filed 2020-11-06 |
| 2019-06-30 | $36.12M 10-Q · filed 2020-08-03 |
| 2019-03-31 | $28.02M 10-Q · filed 2020-05-08 |
| 2018-12-31 | $13.07M 10-K · filed 2021-02-26 |
| 2018-09-30 | $10.02M 10-Q · filed 2019-11-07 |
| 2018-06-30 | $12.13M 10-Q · filed 2019-08-08 |
| 2017-12-31 | $4.50M 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B |